Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Euro Q4 Earnings Preview: GSK, Sanofi, Bayer And Reckitt

Jan 24 2022

• By Tom Gallen

Q4 written on a speechbubble — • Source: Shutterstock

Related Content

RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

Mar 02 2020

Sanofi Catching Up To Market Growth Rates As Q3 Sales Rise Double Digits

Oct 29 2021

GSK Raises Product Prices in US And Europe As Costs Rise

Oct 28 2021

Reckitt Raises Guidance Following Sharp Improvement In Cold & Flu Sales

Oct 27 2021

GSK Rejects £50bn Bid For Consumer Healthcare From Unilever

Jan 17 2022

Successful Innovation And Supplement Gains Drive 'Exceptional' Q3 For Bayer

Nov 09 2021

With Investor Support Thin On The Ground, Unilever Won't Up Bid For GSK Consumer Healthcare

Jan 20 2022

Sanofi's New Consumer Chief Identifies 'Untapped Potential' In Digital

Oct 30 2020

Additional Topics

Europe Sales & Earnings Business Strategies Dietary Supplements OTC Drugs Consumer

More from Europe

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window